Assement of the risks of the use of food supplements and ther drug interactions in the elderly population
Avaliação dos riscos do uso de suplementos alimentares e suas interações medicamentosas na população idosa
Palavras-chave:
Drug interactions, Old man, Dietary supplements, Food suplementsResumo
OBJECTIVE: To assess the risks of using dietary supplements and their drug interactions in the elderly population. METHODOLOGY: This is a descriptive-discursive review, carried out on the VHL, Ministry of Health and Scielo portals. Inclusion criteria were articles with a 10-year version that discussed drug interactions among the elderly. Exclusion criteria Researches that discuss these topics in non-senile population. OUTCOME: As the dietary supplement market expands globally, recognition of drug and supplement interactions is vital to preventing morbidity and mortality. However, the risks of combinations are little known by consumers and there is an increase in reports of hepatotoxicity; hypotension; hypoglycemia and platelet antiaggregation, in addition to reduced pharmacological efficacy or bioavailability. CONCLUSION: Food supplementation when administered with drugs incorrectly causes interaction, leading to ineffectiveness in the treatment by reducing absorption or potentiating the action. Furthermore, the SFD is underreported and little elucidated, which compromises assessing the nature of these interactions.
Downloads
Referências
AGBABIAKA, T. B., et al. “Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey.” The British Journal of General Practice: the journal of the Royal College of General Practitioners vol. 68, n. 675, p.711-717, 2018.
BEGOTTI, R. L.; SATO, M. O; SANTIAGO, R. M. Hepatotoxicidade relacionada ao uso de suplementos herbais e dietéticos (HDS). Revista Fitos, v. 11, n. 1, p. 81-94, 2017.
BOUCHER, B. J. “The problems of vitamin D insufficiency in older people.” Aging and disease. v. 3, n. 4, p. 313-329, 2012.
BEN- ARYE, E., et al. “Asking patients the right questions about herbal and dietary supplements: Cross cultural perspectives.” Complementary Therapies in Medicine v. 22, n. 2, p. 304-310, 2014.
DONOVAN, J. L et al. Green tea (Camellia sinensis) extract does not alter cytochrome P450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos., v. 32, p. 906–8, 2004.
GELLER, A. I et al. “Emergency Department Visits for Adverse Events Related to Dietary Supplements.” The New England Journal of medicine. v. 373, n.16, p.1531-1540, 2015.
GAHCHE, J. J., et al. Dietary supplement use was very high among older adults in the United States in 2011 –2014. The Journal of Nutrition, v. 147, n.10, p. 1968 -1976, 2017.
GALLGHER, J.C.; SMITH, L.M.; YALAMANCHILI, V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause, v. 21, n. 11, p. 1173–1180, 2014.
JACOMINI, L.C.L., et al. Interações medicamentosas: uma contribuição para o uso racional de imunossupressores sintéticos e biológicos. Rev Bras Reumatol., v.51, n.2, p.161-174, 2011.
KNUDSEN, J. F.; SOKOL, G. H. Potential Glucosamine ‐ Warfarin interaction resulting in increased international normalized ratio: Case report and review of the literature and MedWatch database. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, v. 28, n. 4, p. 540-548, 2008.
KUPIEC, T.; RAJ, V. “Fatal seizures due to potential herb-drug interactions with Ginkgo biloba.” Journal of Analytical Toxicology.v. 29, n.7, p.755-758, 2005.
LOPES, E. M., et al. Interação fármaco alimento/nutriente potenciais em pacientes pediátricos hospitalizados. Revista de Ciências Farmacêuticas Básica e Aplicada, v.34, n.1, p. 131-135, 2013.
LICATA, A.; MACALUSO, F. S.; CRAXI, A. Herbal hepatotoxicity: a hidden epidemic. Internal Emergency Medicine, v.8, p. 13-22, 2013.
LEVY I., et al. “Adverse events associated with interactions with dietary and herbal supplements among inpatients.” British Journal of Clinical Pharmacology. v. 83, n. 4, p. 836-845, 2017.
HOEFLER, R. Interações medicamentosas: Formulário Terapêutico Nacional 2008. Série B. Textos Básicos de Saúde. Brasília (Brasil). Ministério da Saúde, 2008. 30-3 p. Disponível em: http:// www.opas.org.br/medicamentos/ [Acesso em 05 de dezembro de 2008].
MARQUITO, A.B., et al. Interação medicamentosa potencial em pacientes com doença renal crônica. J Bras Nefrol., v.36, n.1, p.26-34, 2014.
PRENTICE, R.L., et al. Incidence of milk alkali syndrome in the Women’s Health Initiative clinical trial and cohort study: response to Neupane. Osteoporos Int., v. 41, n. 25, p. 1195, 2014.
ROSS, A. C., et al. “The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.” The Journal of Clinical Endocrinology and Metabolism. v..96, n.1, p. 53-58, 2011.
SADOVSKY, R. et al. “Patient use of dietary supplements: a clinician's perspective.” Current Medical Research and Opinion. v. 24, n.4, p.1209-1216, 2008.
STICKEL, F.; SHOUVAL, D. “Hepatotoxicity of herbal and dietary supplements: an update.” Archives of Toxicology. v. 89, n.6, p. 851-865, 2015.
SHADE, M. Y., et al. “Analysis of oral dietary supplement use in rural older adults.” Journal of Clinical Nursing.v. 28, n.9-10, p.1600-1606, 2019.
TSAI, H.H., et al. “Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review.” International Journal of Clinical Practice. v. 66, n.1, p. 1056-1078, 2012.
TARN, D.M., et al. A Cross-Sectional Study of Provider and Patient Characteristics Associated with Outpatient Disclosures of Dietary Supplement Use. Patient Educ Couns., v. 98, n.7, p. 830-836, 2015.
YIN, O.P.Q., et al. Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics, v. 14, p. 841–850, 2004.
WACHIRA, J. K.; LARSON, M. K.; HARRIS, W. S. n -3 fatty acids affect haemostasis but do not increase the risk of bleeding: Clinical observations and mechanistic insights. British Journal of Nutrition, v. 111, n. 9, p. 1652-1662, 2014.
WERBA, J.P., et al. The effect of green tea on simvastatin tolerability. Ann Intern Med., v.149, p. 286–287, 2008.
